Teva Canada Innovation
Call for patient/clinician input open:
Call for patient/clinician input closed:
NOC Status at Filing:
Manufacturer Requested Reimbursement Criteria1:
For the prevention of migraine in adults who have at least 4 migraine days per month.
Indicated for the prevention of migraine in adults who have at least 4 migraine days per month.
Reimburse with clinical criteria and/or conditions
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.